Cardiovascular health remains a global concern, and one of the reasons that consumers seek protective benefits of dietary supplementation. As much as 80% of consumers in Europe and the US recognize the link between good heart health and good overall health (FMCG).
In recent years, there has been a strong focus on the role of arterial stiffness impacting cardiovascular health, as well as the discovery of the vitamin K-dependent protein Matrix Gla Protein (MGP).
MGP is the most potent modulator of vascular calcification known, provided the body has enough Vitamin K2 to activate it.
MenaQ7® is the only clinically proven Vitamin K2 as MK7 for cardiovascular health with groundbreaking studies. The 3-year study showed a nutritional dose of MenaQ7® taken daily not only inhibited age-related arterial stiffening, but also promoted vascular elasticity.
Choose MenaQ7® to support your heart health claims with science!
Latest news & videos
- MenaQ7®
- News
- Press Release
- Sep 22, 2023
New Clinical Evidence: MenaQ7® K2 Supports Normal Blood Pressure
Gnosis is thrilled to share additional evidence affirming the protective effects of vitamin K2...
- News
- Quatrefolic
- Reproduction & Women's Health
Quatrefolic® 360° collection: Active Folate and Anemia
Vitamin deficiency anemia is a lack of healthy red blood cells caused by a...
- Emothion
- Lynside®
- MenaQ7®
- Sep 15, 2023
Join us at Vitafoods Asia booth G11
Gnosis by Lesaffre will be present at Vitafoods Asia this coming 20-22 September. Join...
